Regulacje i polityka gospodarcza · 30/10/1998

National Cancer Institute Seeks Pharmaceutical Companies for CRADA on Dendritic Cell Research

The National Cancer Institute is seeking Cooperative Research and Development Agreements with pharmaceutical or biotechnology companies to develop methods for generating and expanding dendritic cells to elicit specific immune responses, in line with the Federal Technology Transfer Act of 1986 and the National Technology Transfer and Advancement Act of 1995.